Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Connect Twitter with Market Wire News

ATNM - Actinium Pharmaceuticals Stock Trading

home / stock / atnm

Actinium Pharmaceuticals Inc.(NYSE: ATNM) stock trading description contact officers and directors.
About Actinium Pharmaceuticals Inc.
Actinium Pharmaceuticals, Inc. ATNM.OB is a New York based biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium s targeted radiotherapy is based on its proprietary delivery platform for the therapeutic utilization of alpha emitting actinium and bismuth and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. The Company s lead radiopharmaceutical Iomab TM B will be used in preparing patients for hematopoietic stem cell transplant, commonly referred to as bone marrow transplant. The Company is conducting a single, pivotal, multicenter Phase clinical study of Iomab B in refractory and relapsed Acute Myeloid Leukemia AML patients over the age of with a primary endpoint of durable complete remission. The company s second program, Actimab A, is continuing its clinical development in a Phase / trial for newly diagnosed AML patients over the age of in a single arm multicenter trial.
Stock Information

Actinium Pharmaceuticals Inc. Company Name:

ATNM Stock Symbol:

NYSE Market:

Get ATNM Alerts

News, Short Squeeze, Breakout and More Instantly...

Ad

KITTEE (KTE) Ad
RECENT ATNM NEWS
  • ATNM - Actinium to Present at the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference

    Actinium to Present at the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference Actinium to Present at the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference PR Newswire NEW YORK , Sept. 26, 2022 /PRNewswire/ -- Actinium Phar...

  • ATNM - Actinium Pharmaceuticals Announces Iomab-B SIERRA Trial Database Lock, Provides Corporate Update Highlighting Key Upcoming Milestones

    Actinium Pharmaceuticals Announces Iomab-B SIERRA Trial Database Lock, Provides Corporate Update Highlighting Key Upcoming Milestones PR Newswire On track to report topline data from the Pivotal Phase 3 SIERRA trial for Iomab-B in Q4 2022 Overall survival data from...

  • ATNM - Actinium Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

    Actinium Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference PR Newswire NEW YORK , Sept. 8, 2022 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company) a leader in the...

  •
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Article Banner Advertisement Program

Boost your Articles

The Banner Advertisement Program is designed to Boost your article through a targeted audience.

p>

Pricing and information can be found here.Coins

Each coin will allow 12 hours of Banner advertisement placement everywhere on the Market Wire News platform, included in all emails and other various CWN Media platformsIt also inclused pop up to any new visitor to the site..

Once you receive the coins you can start the advertisement by clicking the button located next to your article in your list of article in your list of articles.

Every twelve hours the ads will automatically stop. You may continue the advertisement for another twelve hours at any time by pressing the button located next to your article in your list of articles. Each time you continue a coin will be withdrawn from your account.

Sign up or login to continue

Sign up or login to continue.

Forgot password?


Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

Follow @marketwirenews

| Facebook

| Telegram

| LinkedIn

| Reddit

| Discord

Contact

Privacy

Terms of Service

Disclaimer

© 2022 Market Wire News